凯莱英(06821)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

06821 凯莱英

劳动节休市 04-30 16:08:13

105.400

-4.200

-3.83%

最高111.000	最低105.000	成交量64.78万
今开109.800	昨收109.600	日振幅5.47%
总市值380.49亿	流通市值29.04亿	总股本3.61亿
成交额6,919万	换手率2.35%	流通股本2,755万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"06821","market":"HK","secType":"STK","nameCN":"凯莱英","latestPrice":105.4,"timestamp":1777536493008,"preClose":109.6,"halted":0,"volume":647800,"delay":0,"changeRate":-0.038321167883211577,"floatShares":27553260,"shares":361000000,"eps":3.623766008945427,"marketStatus":"劳动节休市","change":-4.2,"latestTime":"04-30 16:08:13","open":109.8,"high":111,"low":105,"amount":69189534,"amplitude":0.054745,"askPrice":105.4,"askSize":800,"bidPrice":105.1,"bidSize":600,"shortable":3,"etf":0,"ttmEps":3.5641114811652557,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1777858200000},"marketStatusCode":7,"adr":0,"listingDate":1639065600000,"exchange":"SEHK","adjPreClose":109.6,"dividendRate":0.011406,"openAndCloseTimeList":[[1777512600000,1777521600000],[1777525200000,1777536000000]],"volumeRatio":0.554394,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"002821","market":"SZ","secType":"STK","nameCN":"凯莱英","latestPrice":125.56,"timestamp":1777532400000,"preClose":126.8,"halted":0,"volume":7597400,"delay":0,"premium":"-26.80"}},"requestUrl":"/m/hq/s/06821","defaultTab":"news","newsList":[{"id":"2631469575","title":"凯莱英遭Schroders PLC减持25.89万股 每股作价约113.53港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2631469575","media":"新浪港股","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631469575?lang=zh_cn&edition=full","pubTime":"2026-04-30 08:01","pubTimestamp":1777507260,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n　　香港联交所最新资料显示，4月28日，Schroders PLC减持凯莱英（06821）25.89万股，每股作价113.5268港元，总金额约为2939.21万港元。减持后最新持股数目为538.03万股，最新持股比例为19.33%。\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：卢昱君","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2026-04-30/doc-inhwfpqn7266535.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0132","06821","EWH","BK0239","BK1191","002821","LU1328615791.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631512887","title":"Norges Bank减持凯莱英(06821)18.49万股 每股作价约102.86港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2631512887","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631512887?lang=zh_cn&edition=full","pubTime":"2026-04-29 20:55","pubTimestamp":1777467357,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，香港联交所最新资料显示，4月27日，Norges Bank减持凯莱英(06821)18.49万股，每股作价102.8593港元，总金额约为1901.87万港元。减持后最新持股数目为405.66万股，最新持股比例为14.57%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1436564.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0132","BK0239","EWH","LU1328615791.USD","002821","BK1191","06821"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631551724","title":"交银国际：上调凯莱英(06821)目标价至136.6港元 维持“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2631551724","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631551724?lang=zh_cn&edition=full","pubTime":"2026-04-29 10:31","pubTimestamp":1777429898,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，交银国际发布研报称，将凯莱英(06821,002821.SZ)H股目标价调高至136.6港元，A 股为159.2元人民币，维持“买入”的投资评级。基于首财季的超预期业绩表现，交银国际上调凯莱英2026-28年经调整净利润预测2-14%。该行指，尽管面临汇率波动和小份子业务高基数的影响，该公司在2026年首财季录得强劲且超预期的利润增长，反映出新兴业务订单需求的持续高涨和经营效率的提升。公司在高景气度赛道的后期订单规模扩大和前瞻性投入，可望带来较强的长期高增长确定性。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1435962.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06821","EWH","002821"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1111213661","title":"异动解读 | 凯莱英盘中大跌5.16%，因股东转仓及一季度净利润下滑","url":"https://stock-news.laohu8.com/highlight/detail?id=1111213661","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1111213661?lang=zh_cn&edition=full","pubTime":"2026-04-29 09:34","pubTimestamp":1777426465,"startTime":"0","endTime":"0","summary":"凯莱英（06821）今日盘中股价大跌5.16%，引起市场关注。消息面上，公司早间披露的信息显示，有股东将所持股票由花旗银行转入摩根士丹利香港证券，转仓市值达1.77亿港元，占总股本约6.06%。此类大额股份转移操作有时会被市场解读为潜在的减持信号或股东结构变动，可能引发投资者担忧。同时，凯莱英发布的2026年第一季度业绩显示，尽管营业收入同比增长16.91%至约18.02亿元，但归属于上市公司股东的净利润约为3.04亿元，同比减少6.82%；扣除非经常性损益的净利润约为2.72亿元，同比下滑10.88%。核心盈利指标的下滑，可能未能达到部分市场预期，共同导致了股价的承压下跌。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["06821"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631553574","title":"凯莱英(06821)股东将股票由花旗银行转入摩根士丹利香港证券 转仓市值1.77亿港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2631553574","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631553574?lang=zh_cn&edition=full","pubTime":"2026-04-29 08:17","pubTimestamp":1777421853,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，香港联交所最新资料显示，4月28日，凯莱英(06821)股东将股票由花旗银行转入摩根士丹利香港证券，转仓市值1.77亿港元，占比6.06%。凯莱英发布2026年第一季度业绩，营业收入约18.02亿元，同比增长16.91%；归属于上市公司股东的净利润约3.04亿元，同比减少6.82%；扣非净利约2.72亿元，同比减少10.88%；基本每股收益0.84元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1435891.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4559","LU0162691827.USD","LU0795875086.SGD","LU1366192091.USD","LU1791807156.HKD","BK4516","LU1328615791.USD","LU2125154778.USD","LU0006306889.USD","LU1162221912.USD","LU0158827948.USD","LU0130517989.USD","LU0320765646.SGD","LU0225283273.USD","LU1074936037.SGD","LU1791710582.SGD","LU2089284900.SGD","LU0528227936.USD","LU1244550494.USD","LU1244550577.SGD","06821","LU0314106906.USD","LU0795875169.SGD","BK4581","LU0072461881.USD","BK4534","LU0106261372.USD","LU1244550221.USD","LU2133065610.SGD","LU1201861249.SGD","BK4127","LU0477156953.USD","LU2023251221.USD","LU1668664300.SGD","LU0130102774.USD","LU0158827781.USD","002821","LU2271345857.HKD","LU0052756011.USD","LU0170899867.USD","LU0128525689.USD","LU1732799900.SGD","161027","BK4504","LU2028103732.USD","LU0106831901.USD","BK4588","LU1791710400.SGD","BK4566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630302781","title":"和讯信息张汇：创业板4连阴！科技股要分化？","url":"https://stock-news.laohu8.com/highlight/detail?id=2630302781","media":"和讯网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630302781?lang=zh_cn&edition=full","pubTime":"2026-04-28 20:48","pubTimestamp":1777380532,"startTime":"0","endTime":"0","summary":"4月28日，和讯信息张汇分析称今天三大指数继续调整，但分化也是很明显，这两天主板没怎么跌，整体震荡，但创业板已经连调四天，今天已经跌破了10日线，万物皆轮动，月初怎么涨的，月末就怎么调，还好，这月整体涨幅还是可以的。整体而言，随着节前效应逐步显现，目前市场还是以震荡轮动为主，把握个股节奏是关键。药名昨晚一季报，营业收入、归母净利润均创下历史同期新高，超出预期。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://stock.hexun.com/2026-04-28/224076840.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","02359","159967","000905.SH","512510","000300.SH","399001","510300","515890","603259","512880","002821","000688.SH","06821","BK1147","159915","510880","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630376304","title":"凯莱英涨10.00%，开源证券三周前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2630376304","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630376304?lang=zh_cn&edition=full","pubTime":"2026-04-28 16:31","pubTimestamp":1777365114,"startTime":"0","endTime":"0","summary":"今日凯莱英涨10.00%，收盘报129.49元。2026年4月1日，开源证券研究员余汝意发布了对凯莱英的研报《公司信息更新报告：收入利润高质增长，多赛道景气共振下迈向加速周期》，该研报对凯莱英给出“买入”评级。研报中预计2026-2028年公司归母净利润为15.07/18.59/23.12亿元，EPS为4.18/5.15/6.41元，当前股价对应PE为24.1/19.5/15.7倍，维持“买入”评级。证券之星数据中心计算显示，对该股盈利预测较准的分析师团队为中国银河的宋丽莹、程培。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042800049225.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002821","06821","161027"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630132145","title":"别只盯着AI！CXO龙头绩后狂飙，医药赛道要接棒？","url":"https://stock-news.laohu8.com/highlight/detail?id=2630132145","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630132145?lang=zh_cn&edition=full","pubTime":"2026-04-28 12:12","pubTimestamp":1777349565,"startTime":"0","endTime":"0","summary":"新一轮行情蓄势待发？","market":"sh","thumbnail":"https://img3.gelonghui.com/24523-2e652654-d4de-433f-93f9-afc3a2669c93.jpg?guru_height=718&guru_width=1280&guru_size=85166","type":0,"news_type":0,"thumbnails":["https://img3.gelonghui.com/24523-2e652654-d4de-433f-93f9-afc3a2669c93.jpg?guru_height=718&guru_width=1280&guru_size=85166"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/4574522","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["BK1574","LU2125910500.SGD","BK1515","BK0132","BK1161","LU0320764599.SGD","BK1191","BK0239","LU1328615791.USD","09939","06821","LU2045819591.USD","CHAT","LU2242644610.SGD","AIPO","BK1576","LU0708995583.HKD","603127","BK1583","ARTY","LU1046422090.SGD","02359","159938","LU0052750758.USD","AGIX","BK1141","CXO","LU0348767384.USD","BK0216","LU0348766576.USD","002821","06127"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630323318","title":"港股异动 | 凯莱英(06821)涨超10% 一季度经调整归母净利增近28% 新兴业务收入同比大增七成","url":"https://stock-news.laohu8.com/highlight/detail?id=2630323318","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630323318?lang=zh_cn&edition=full","pubTime":"2026-04-28 11:22","pubTimestamp":1777346548,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，凯莱英涨超10%，截至发稿，涨10%，报115.5港元，成交额1.72亿港元。消息面上，4月27日晚，凯莱英发布2026年第一季度业绩，营业收入约18.02亿元，同比增长16.91%；归属于上市公司股东的净利润约3.04亿元，同比减少6.82%。分业务来看，一季度小分子CDMO 业务收入12亿元，同比增长 0.43%，恒定汇率下增长 3.26%；新兴业务收入5.98亿元，同比增长74.07%，主要是化学大分子和生物大分子业务板块增长强劲。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1435083.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","BK4585","002821","BK0132","VXUS","BK1191","BK4588","LU1328615791.USD","06821"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630475973","title":"异动快报：凯莱英（002821）4月28日9点39分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2630475973","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630475973?lang=zh_cn&edition=full","pubTime":"2026-04-28 09:40","pubTimestamp":1777340457,"startTime":"0","endTime":"0","summary":"证券之星4月28日盘中消息，9点39分凯莱英触及涨停板。其所属行业医疗服务目前上涨。领涨股为普瑞眼科。该股为减肥药，健康中国，合成生物概念热股，当日减肥药概念上涨1.37%，健康中国概念上涨1.22%，合成生物概念上涨0.77%。4月27日的资金流向数据方面，主力资金净流入8185.01万元，占总成交额7.84%，游资资金净流入2559.26万元，占总成交额2.45%，散户资金净流出1.07亿元，占总成交额10.29%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042800029854.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1191","BK0132","002821","06821","LU1328615791.USD","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1179232423","title":"异动解读 | 凯莱英盘中大涨5.81%，新兴业务收入激增74%成亮点","url":"https://stock-news.laohu8.com/highlight/detail?id=1179232423","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1179232423?lang=zh_cn&edition=full","pubTime":"2026-04-28 09:40","pubTimestamp":1777340405,"startTime":"0","endTime":"0","summary":"凯莱英今日盘中大涨5.81%，引起了市场的广泛关注。消息面上，凯莱英最新发布的一季度业绩报告显示，公司营业收入同比增长16.91%，达到18.02亿元。尽管归属于上市公司股东的净利润因汇兑损失影响而同比下滑6.82%，但公司新兴业务表现极为亮眼，收入达到5.98亿元，同比大幅增长74.07%，主要得益于化学大分子和生物大分子业务的强劲增长。此外，更能反映公司核心经营状况的“经调整归属于上市公司股东的净利润”达到4.23亿元，同比增长27.91%，表明公司主营业务的盈利能力和增长态势实际上在持续增强。市场可能将关注点放在了公司强劲的收入增长和新兴业务的巨大潜力上，从而推动了股价的上涨。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["06821"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1141783979","title":"凯莱英2026年第一季度营收18.02亿元，经调整净利润4.23亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=1141783979","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1141783979?lang=zh_cn&edition=full","pubTime":"2026-04-27 21:02","pubTimestamp":1777294969,"startTime":"0","endTime":"0","summary":"凯莱英发布的2026年第一季度财报显示，公司实现营收18.02亿元，同比增长16.91%。期内经调整归属于上市公司股东的净利润4.23亿元，同比上涨27.91%。公司整体毛利率为43.02%，经营活动产生的现金流净额约5.27亿元，同比增长17.21%。毛利率方面，新兴业务和小分子CDMO业务分别较去年同期提升2.03个百分点和1.64个百分点，带动整体利润水平进一步优化。在费用端，公司逐步采取控本提效策略，整体毛利率较去年同期稳中有升，同时推动经营现金流保持增长。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"凯莱英2026年第一季度营收18.02亿元，经调整净利润4.23亿元","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06821"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2630367452","title":"凯莱英：一季度净利润3.04亿元 同比减少6.82%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630367452","media":"南方财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630367452?lang=zh_cn&edition=full","pubTime":"2026-04-27 18:20","pubTimestamp":1777285200,"startTime":"0","endTime":"0","summary":"【凯莱英：一季度净利润3.04亿元 同比减少6.82%】凯莱英公告，2026年第一季度实现营业收入18.02亿元，同比增长16.91%；归属于上市公司股东的净利润3.04亿元，同比减少6.82%；经营活动产生的现金流量净额5.27亿元，同比增长17.21%。净利润同比下降主要系本期人民币升值导致汇兑损失增加，而上年同期为汇兑收益。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202604273720337241.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["002821","06821"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630364329","title":"高盛：内地CDMO板块稳健 看好药明康德(02359)、凯莱英(06821)等","url":"https://stock-news.laohu8.com/highlight/detail?id=2630364329","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630364329?lang=zh_cn&edition=full","pubTime":"2026-04-27 17:25","pubTimestamp":1777281907,"startTime":"0","endTime":"0","summary":"股份方面，该行对评级为“买入”的股份持更正面态度，包括药明康德 、凯莱英 、微创机器人 及精锋医疗 。另外，该行将爱康医疗 评级升至“买入”，反映其执行力重启、利润率改善及中期能见度更清晰，并将微泰医疗 升级至“中性”，因国内竞争影响优于预期，且有序达成2026年指引。前者受累于持续的VBP相关利润压力及短期增长乏力，后者收入加速回升但仍不明朗，上行空间有限。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1434465.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1997244956.HKD","LU0348766576.USD","LU1934453819.USD","LU0456842615.SGD","02359","LU0173614495.USD","BK4139","06821","BK1141","LU0708995583.HKD","LU0287142896.SGD","LU1979443071.USD","BK1617","LU0320764599.SGD","LU2328871848.SGD","BK1583","02252","LU1997245094.SGD","BK0132","BK1576","BK0216","LU1046422090.SGD","002821","BK1222","LU2125910500.SGD","LU1328615791.USD","01789","BK1585","LU2045819591.USD","LU1969619763.USD","BK1191","LU1997245177.USD","LU2242644610.SGD","BK1100","CDMO","01066","02675","LU2488822045.USD","LU2495084118.USD","LU0052750758.USD","LU1808992512.USD","LU0348767384.USD","603259","BK1589","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630736342","title":"凯莱英尾盘涨超5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630736342","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630736342?lang=zh_cn&edition=full","pubTime":"2026-04-27 15:47","pubTimestamp":1777276022,"startTime":"0","endTime":"0","summary":"4月27日，凯莱英(06821.HK)尾盘涨超5%，截至发稿涨5.13%，报104.5港元，成交额1.18亿港元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202604273720073386.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202604273720073386.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1191","002821","LU1328615791.USD","06821","BK0132","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630635623","title":"港股异动 | 凯莱英(06821)尾盘涨超5% 20亿元化学大分子CDMO项目落地天津 TIDES持续扩能扩产","url":"https://stock-news.laohu8.com/highlight/detail?id=2630635623","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630635623?lang=zh_cn&edition=full","pubTime":"2026-04-27 15:41","pubTimestamp":1777275714,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，凯莱英(06821)尾盘涨超5%，截至发稿，涨5.13%，报104.5港元，成交额1.18亿港元。消息面上，凯莱英化学大分子CDMO项目落地天津经开区。该项目将进一步提升公司在多肽、寡核苷酸（TIDES）等新分子类型的CDMO一站式服务能力，更好满足全球合作伙伴的多元需求。浙商证券此前指出，考虑到凯莱英小分子CDMO不错的在手PPQ项目，我们认为小分子CDMO业务仍具有较强的成长性。新兴业务板块多肽、寡核苷酸、ADC相关CDMO、制剂CDMO等仍有较大的成长空间和业绩弹性，","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1434326.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4139","BK1191","BK4585","CDMO","VXUS","BK0132","002821","06821","LU1328615791.USD","BK4588","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1102526373","title":"异动解读 | 高盛看好并给予买入评级，凯莱英盘中大涨5.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=1102526373","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1102526373?lang=zh_cn&edition=full","pubTime":"2026-04-27 15:22","pubTimestamp":1777274574,"startTime":"0","endTime":"0","summary":"凯莱英（06821.HK）今日盘中股价大幅上涨5.43%，引起了市场的广泛关注。消息面上，高盛（Goldman Sachs）发布了一份关于内地医药行业的研究报告，指出CDMO（合同研发生产组织）企业的业绩反映该板块周期维持稳健。报告特别对凯莱英持正面态度，并给予“买入”评级，这增强了投资者对公司未来前景的信心，从而推动了股价的上涨。高盛在报告中强调，CDMO板块的能见度日益取决于后期及商业化项目的敞口，而非早期融资条件，并且人工智能（AI）尚未对订单量、订单积压质量或定价造成结构性破坏。该行还看好其他一些医药股，包括药明康德、微创机器人及精锋医疗等。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["06821"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629890926","title":"凯莱英午后涨近6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2629890926","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629890926?lang=zh_cn&edition=full","pubTime":"2026-04-24 14:29","pubTimestamp":1777012197,"startTime":"0","endTime":"0","summary":"4月24日，凯莱英(06821.HK)午后涨近6%，截至发稿，涨5.49%，报97.1港元，成交额4458.26万港元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202604243717891296.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202604243717891296.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK0239","002821","BK0132","BK1191","LU1328615791.USD","06821"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1193863857","title":"异动解读 | 凯莱英盘中大涨5.87%，20亿元化学大分子创新药CDMO项目落地天津经开区","url":"https://stock-news.laohu8.com/highlight/detail?id=1193863857","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1193863857?lang=zh_cn&edition=full","pubTime":"2026-04-24 14:29","pubTimestamp":1777012179,"startTime":"0","endTime":"0","summary":"凯莱英今日盘中大涨5.87%，引起了市场的广泛关注。消息面上，凯莱英与天津经开区管委会签署合作备忘录，计划投资20亿元人民币，在天津经开区持续扩建化学大分子创新药CDMO研发生产基地。公开数据显示，2025年凯莱英化学大分子CDMO板块实现营业收入10.28亿元，同比增长123.72%，已成为公司增长最为迅速的业务单元。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["06821"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629974938","title":"港股异动 | 凯莱英(06821)午后涨近6% 20亿元化学大分子创新药CDMO项目落地天津经开区","url":"https://stock-news.laohu8.com/highlight/detail?id=2629974938","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629974938?lang=zh_cn&edition=full","pubTime":"2026-04-24 14:26","pubTimestamp":1777011981,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，凯莱英午后涨近6%，截至发稿，涨5.49%，报97.1港元，成交额4458.26万港元。公开数据显示，2025年凯莱英化学大分子CDMO板块实现营业收入10.28亿元，同比增长123.72%，成为公司增长最为迅速的业务单元。公司预计26年多肽PPQ项目将达4个且多肽固相合成产能将从25年底的4.5万升增至26年底的6.9万升。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1433271.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","002821","BK4585","BK1574","CDMO","VXUS","159992","LU1328615791.USD","BK1161","06978","BK4139","06821","BK4588","BK0132","BK0239"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.asymchem.com","stockEarnings":[{"period":"1week","weight":0.145},{"period":"1month","weight":0.1582},{"period":"3month","weight":0.294},{"period":"6month","weight":0.2593},{"period":"1year","weight":0.9442},{"period":"ytd","weight":0.4803}],"compareEarnings":[{"period":"1week","weight":-0.0054},{"period":"1month","weight":0.0399},{"period":"3month","weight":-0.0588},{"period":"6month","weight":-0.005},{"period":"1year","weight":0.1653},{"period":"ytd","weight":0.0057}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"凯莱英医药集团（天津）股份有限公司是一家主要从事提供医药外包一站式综合服务的中国公司。该公司的业务包括小分子药物定制研发生产（CDMO）、化学大分子CDMO、临床研究服务、制剂CDMO、生物大分子CDMO、技术输出和合成生物技术。该公司的产品类别涵盖多肽、寡核苷酸、单克隆抗体、抗体偶联药物和信使RNA等。该公司主要在国内外市场开展其业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":-0.058446},{"month":2,"riseRate":0.4,"avgChangeRate":0.006896},{"month":3,"riseRate":0.4,"avgChangeRate":0.004398},{"month":4,"riseRate":0.6,"avgChangeRate":-0.036175},{"month":5,"riseRate":0.5,"avgChangeRate":0.040294},{"month":6,"riseRate":0.5,"avgChangeRate":0.01751},{"month":7,"riseRate":0.5,"avgChangeRate":0.064856},{"month":8,"riseRate":0.25,"avgChangeRate":-0.064097},{"month":9,"riseRate":0.75,"avgChangeRate":0.16322},{"month":10,"riseRate":0,"avgChangeRate":-0.125554},{"month":11,"riseRate":0.5,"avgChangeRate":0.010602},{"month":12,"riseRate":0.25,"avgChangeRate":-0.010177}],"exchange":"SEHK","name":"凯莱英","nameEN":"ASYMCHEM"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.1","shortVersion":"4.42.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"凯莱英(06821)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供凯莱英(06821)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"凯莱英,06821,凯莱英股票,凯莱英股票老虎,凯莱英股票老虎国际,凯莱英行情,凯莱英股票行情,凯莱英股价,凯莱英股市,凯莱英股票价格,凯莱英股票交易,凯莱英股票购买,凯莱英股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"凯莱英(06821)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供凯莱英(06821)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}